A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Clinical Trial ID NCT01441193

PubWeight™ 5.38^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01441193

Top papers